Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03764163 · ClinicalTrials.gov registry record · Early Phase 1
Image and Model Based Analysis of Lung Disease
A Early Phase 1 study, sponsored by Eric A. Hoffman.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 341
- Enrollment target
NCT03764163: Completed Early Phase 1 study, sponsored by Eric A. Hoffman.
NCT03764163 is a Early Phase 1 study that has completed, run by Eric A. Hoffman. The registered enrollment target is 341 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (543% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03764163, a Early Phase 1 study, has completed, sponsored by Eric A. Hoffman.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 341 participants
- Enrollment target
Study Summary
The purpose of this research study is to develop CT scanning and image analysis techniques to help define and measure several key properties of the pulmonary system that cannot be obtained by other tests or exams.
Primary Outcome
Normal aging process of the lungs compared to common smoking related lung diseases.
Interventions
- BEHAVIORAL Questionnaires
- DIAGNOSTIC_TEST MRI
- DIAGNOSTIC_TEST Pulmonary Function Test
- DIAGNOSTIC_TEST CT Scans
- BIOLOGICAL Xenon gas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 341 participants |
| Start Date | 1997-09-30 |
| Est. Completion | 2015-06-05 |
| Phase | Early Phase 1 |
What the finished NCT03764163 record still lists
NCT03764163 is an interventional study that assigns participants to a tested intervention. The registered 341 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (543% higher).
The record links to 0 conditions, and to 5 interventions - of which Questionnaires is the first listed.
NCT03764163 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03764163 about?
NCT03764163 is a clinical study titled "Image and Model Based Analysis of Lung Disease". The purpose of this research study is to develop CT scanning and image analysis techniques to help define and measure several key properties of the pulmonary system that cannot be obtained by other tests or exams.
What is the current status of trial NCT03764163?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 341 participants. The study started on 1997-09-30. Estimated completion is 2015-06-05.
What interventions are being tested in trial NCT03764163?
The interventions under investigation include: Questionnaires (BEHAVIORAL), MRI (DIAGNOSTIC_TEST), Pulmonary Function Test (DIAGNOSTIC_TEST), CT Scans (DIAGNOSTIC_TEST), Xenon gas (BIOLOGICAL).
Who is sponsoring clinical trial NCT03764163?
This trial is sponsored by Eric A. Hoffman, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03764163's enrollment target sits among peer trials
341 31st of 2000 higher than 1,970 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06852170 · 341 participants · NA
Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention
- NCT05283850 · 342 participants · Phase 2
Surviving PEA in Roanoke (SPEAR) Study
- NCT05714085 · 342 participants · Phase 2
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- NCT06188702 · 342 participants · Phase 1
S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI